November 28, 2018
The U.S. Food and Drug Administration has updated and released two draft guidance documents (here and here) that aim to help manufacturers of in vitro diagnostic (IVD) devices apply for and receive Clinical Laboratory Improvement Amendments (CLIA) waivers.
Date: Wednesday, January 9, 2019
Time: 1:00 – 2:30 PM Eastern Time
You can access the webinar information here.